Chen‐Tu Wu
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 7
-
- Lung Cancer Treatments and Mutations 24
- Sarcoma Diagnosis and Treatment 12
- Lung Cancer Diagnosis and Treatment 11
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 6
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 7
- Oral Surgery top 5%
-
- Salivary Gland Tumors Diagnosis and Treatment 9
- Co-authors
- Yih‐Leong ChangYung-Chie LeePan‐Chyr YangJin‐Yuan ShihMong‐Wei LinChing‐Yao YangTse-Ming HongSzu‐Hua Pan
- Journals
- Annals of Surgical Oncology (9 papers)Lung Cancer (5 papers)Journal of Thoracic and Cardiovascular Surgery (5 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Chen‐Tu Wu
125 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 113
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 1.9k
- Cancer Research 778
- Otorhinolaryngology 127
- Oral Surgery 187
Countries citing papers authored by Chen‐Tu Wu
This map shows the geographic impact of Chen‐Tu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Tu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Tu Wu more than expected).
Fields of papers citing papers by Chen‐Tu Wu
This network shows the impact of papers produced by Chen‐Tu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Tu Wu. The network helps show where Chen‐Tu Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chen‐Tu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 2 | |
| 4 | 2019 | 10 | |
| 5 | 2018 | 27 | |
| 6 | 2017 | 108 | |
| 7 | 2015 | 4 | |
| 8 | 2013 | 38 | |
| 9 | 2013 | 4 | |
| 10 | 2012 | 3 | |
| 11 | 2011 | 63 | |
| 12 | 2009 | 404 | |
| 13 | 2007 | 1 | |
| 14 | 2007 | 9 | |
| 15 | 2007 | 37 | |
| 16 | 2006 | 12 | |
| 17 | 2005 | 54 | |
| 18 | 2004 | 1 | |
| 19 | Clinical observations on dopamine cardiotonic and diuretic action. | 1978 | 1 |
| 20 | [The first case of Conn's disease in Taiwan. (Primary aldosteronism)]. | 1961 | 2 |
About Chen‐Tu Wu
Chen‐Tu Wu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology, Cancer Research and Rheumatology, having authored 130 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), Sarcoma Diagnosis and Treatment (12 papers), Lung Cancer Diagnosis and Treatment (11 papers), Salivary Gland Tumors Diagnosis and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Head and Neck Cancer Studies (7 papers), Lung Cancer Research Studies (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (1.9k citations), Cancer Research (778 citations), Otorhinolaryngology (127 citations) and Oral Surgery (187 citations). Chen‐Tu Wu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Yih‐Leong Chang, Yung-Chie Lee, Pan‐Chyr Yang, Jin‐Yuan Shih, Mong‐Wei Lin, Ching‐Yao Yang, Tse-Ming Hong, Szu‐Hua Pan, Chong‐Jen Yu and Wing‐Kai Chan. Their work appears in journals such as Annals of Surgical Oncology, Lung Cancer, Journal of Thoracic and Cardiovascular Surgery, Oral Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.